JP2013509438A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013509438A5 JP2013509438A5 JP2012537147A JP2012537147A JP2013509438A5 JP 2013509438 A5 JP2013509438 A5 JP 2013509438A5 JP 2012537147 A JP2012537147 A JP 2012537147A JP 2012537147 A JP2012537147 A JP 2012537147A JP 2013509438 A5 JP2013509438 A5 JP 2013509438A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrido
- pyrimidin
- phenylamino
- trifluoromethyl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003118 aryl group Chemical group 0.000 claims 99
- -1 C 3 -C 6 cycloalkyl sulfone Chemical class 0.000 claims 62
- 125000001072 heteroaryl group Chemical group 0.000 claims 38
- 125000000217 alkyl group Chemical group 0.000 claims 37
- 229920006395 saturated elastomer Polymers 0.000 claims 32
- 125000002619 bicyclic group Chemical group 0.000 claims 30
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 30
- 150000001875 compounds Chemical class 0.000 claims 29
- 125000005842 heteroatom Chemical group 0.000 claims 28
- 229910052757 nitrogen Inorganic materials 0.000 claims 27
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 25
- 125000002950 monocyclic group Chemical group 0.000 claims 25
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims 24
- 125000001188 haloalkyl group Chemical group 0.000 claims 20
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 19
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 19
- 229910052760 oxygen Inorganic materials 0.000 claims 19
- 239000001301 oxygen Substances 0.000 claims 19
- 150000003457 sulfones Chemical class 0.000 claims 19
- 150000003462 sulfoxides Chemical class 0.000 claims 19
- 229910052717 sulfur Inorganic materials 0.000 claims 19
- 239000011593 sulfur Substances 0.000 claims 19
- 125000005843 halogen group Chemical group 0.000 claims 17
- 125000000304 alkynyl group Chemical group 0.000 claims 16
- 229910052799 carbon Inorganic materials 0.000 claims 16
- 125000004432 carbon atom Chemical group C* 0.000 claims 16
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 15
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 15
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 14
- 125000000753 cycloalkyl group Chemical group 0.000 claims 14
- 125000003710 aryl alkyl group Chemical group 0.000 claims 11
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 11
- CSBPQHGADOHBPJ-UHFFFAOYSA-N 6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=NC=C2C(=O)NC=CC2=N1 CSBPQHGADOHBPJ-UHFFFAOYSA-N 0.000 claims 10
- 125000003342 alkenyl group Chemical group 0.000 claims 10
- 229910052739 hydrogen Inorganic materials 0.000 claims 10
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 9
- 102000007399 Nuclear hormone receptor Human genes 0.000 claims 8
- 108020005497 Nuclear hormone receptor Proteins 0.000 claims 8
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 6
- 150000003857 carboxamides Chemical class 0.000 claims 5
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 4
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 4
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 claims 3
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 3
- BDTRIDKONHOQQN-UHFFFAOYSA-N 4h-pyrimidin-5-one Chemical compound O=C1CN=CN=C1 BDTRIDKONHOQQN-UHFFFAOYSA-N 0.000 claims 3
- QUCQUTXMTKXZTF-UHFFFAOYSA-N 8-bromo-2-(4-hydroxypiperidin-1-yl)-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)CCN1C1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=C(Br)C2=N1 QUCQUTXMTKXZTF-UHFFFAOYSA-N 0.000 claims 3
- NHWORLVFFPWOCG-UHFFFAOYSA-N 8-bromo-2-[4-hydroxy-4-(hydroxymethyl)piperidin-1-yl]-4-[4-methoxy-3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=C(C(F)(F)F)C(OC)=CC=C1NC1=NC(N2CCC(O)(CO)CC2)=NC2=C1C(=O)NC=C2Br NHWORLVFFPWOCG-UHFFFAOYSA-N 0.000 claims 3
- ULQQRNIWQOCYCI-UHFFFAOYSA-N 8-chloro-2-(4-hydroxypiperidin-1-yl)-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)CCN1C1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=C(Cl)C2=N1 ULQQRNIWQOCYCI-UHFFFAOYSA-N 0.000 claims 3
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 229940124530 sulfonamide Drugs 0.000 claims 3
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 claims 3
- KLLWQQZIWABLMM-UHFFFAOYSA-N 2-(4-aminopiperidin-1-yl)-4-(3-bromoanilino)-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1CC(N)CCN1C1=NC(NC=2C=C(Br)C=CC=2)=C2C(=O)NC=CC2=N1 KLLWQQZIWABLMM-UHFFFAOYSA-N 0.000 claims 2
- GEOYUPAKWBFMCY-UHFFFAOYSA-N 2-(4-aminopiperidin-1-yl)-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1CC(N)CCN1C1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 GEOYUPAKWBFMCY-UHFFFAOYSA-N 0.000 claims 2
- SLIWCDKAMPYVHD-UHFFFAOYSA-N 2-(4-aminopiperidin-1-yl)-8-bromo-4-(4-phenoxyanilino)-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1CC(N)CCN1C1=NC(NC=2C=CC(OC=3C=CC=CC=3)=CC=2)=C2C(=O)NC=C(Br)C2=N1 SLIWCDKAMPYVHD-UHFFFAOYSA-N 0.000 claims 2
- OQWFKMRCKRKWJM-UHFFFAOYSA-N 2-(4-hydroxypiperidin-1-yl)-4-(4-methylsulfonylanilino)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC(N2CCC(O)CC2)=NC2=C1C(=O)NC=C2 OQWFKMRCKRKWJM-UHFFFAOYSA-N 0.000 claims 2
- PFXJJNWJPALFKW-UHFFFAOYSA-N 2-(4-hydroxypiperidin-1-yl)-4-[3-methoxy-5-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound FC(F)(F)C1=CC(OC)=CC(NC=2C=3C(=O)NC=CC=3N=C(N=2)N2CCC(O)CC2)=C1 PFXJJNWJPALFKW-UHFFFAOYSA-N 0.000 claims 2
- VPNJGTRMGOLFFE-HNCPQSOCSA-N 2-[(3r)-3-aminopyrrolidin-1-yl]-8-bromo-4-(4-bromo-3-methylanilino)-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1=C(Br)C(C)=CC(NC=2C=3C(=O)NC=C(Br)C=3N=C(N=2)N2C[C@H](N)CC2)=C1 VPNJGTRMGOLFFE-HNCPQSOCSA-N 0.000 claims 2
- JWDVLBRIYMKSPE-HNCPQSOCSA-N 2-[(3r)-3-aminopyrrolidin-1-yl]-8-bromo-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1[C@H](N)CCN1C1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=C(Br)C2=N1 JWDVLBRIYMKSPE-HNCPQSOCSA-N 0.000 claims 2
- YCQGWGUPQKSACP-PFEQFJNWSA-N 2-[(3r)-3-aminopyrrolidin-1-yl]-8-iodo-4-(4-phenoxyanilino)-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1[C@H](N)CCN1C1=NC(NC=2C=CC(OC=3C=CC=CC=3)=CC=2)=C2C(=O)NC=C(I)C2=N1 YCQGWGUPQKSACP-PFEQFJNWSA-N 0.000 claims 2
- MJZVMIRHKRTFQH-UHFFFAOYSA-N 2-[4-(hydroxymethyl)piperidin-1-yl]-4-[3-methoxy-5-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound FC(F)(F)C1=CC(OC)=CC(NC=2C=3C(=O)NC=CC=3N=C(N=2)N2CCC(CO)CC2)=C1 MJZVMIRHKRTFQH-UHFFFAOYSA-N 0.000 claims 2
- DPDHFMGZOGORQX-UHFFFAOYSA-N 4-(3,4-dimethoxyanilino)-2-[4-hydroxy-4-(hydroxymethyl)piperidin-1-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=C(OC)C(OC)=CC=C1NC1=NC(N2CCC(O)(CO)CC2)=NC2=C1C(=O)NC=C2 DPDHFMGZOGORQX-UHFFFAOYSA-N 0.000 claims 2
- VMPADCYUHYLGQG-UHFFFAOYSA-N 4-(3-bromo-4-methoxyanilino)-2-[4-hydroxy-4-(hydroxymethyl)piperidin-1-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=C(Br)C(OC)=CC=C1NC1=NC(N2CCC(O)(CO)CC2)=NC2=C1C(=O)NC=C2 VMPADCYUHYLGQG-UHFFFAOYSA-N 0.000 claims 2
- JTDGZXKALXMEHQ-UHFFFAOYSA-N 4-(3-bromoanilino)-2-[4-(dimethylamino)piperidin-1-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(N(C)C)CCN1C1=NC(NC=2C=C(Br)C=CC=2)=C2C(=O)NC=CC2=N1 JTDGZXKALXMEHQ-UHFFFAOYSA-N 0.000 claims 2
- MVJILHISNCDSDL-ZDUSSCGKSA-N 4-(3-bromoanilino)-2-[4-[[(2s)-1-hydroxypropan-2-yl]amino]piperidin-1-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(N[C@H](CO)C)CCN1C1=NC(NC=2C=C(Br)C=CC=2)=C2C(=O)NC=CC2=N1 MVJILHISNCDSDL-ZDUSSCGKSA-N 0.000 claims 2
- UWRGLAQTMHMTGR-UHFFFAOYSA-N 4-[4-(4-acetylpiperazin-1-yl)anilino]-2-[4-(hydroxymethyl)piperidin-1-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1NC1=NC(N2CCC(CO)CC2)=NC2=C1C(=O)NC=C2 UWRGLAQTMHMTGR-UHFFFAOYSA-N 0.000 claims 2
- JZJZFCAXXMAKKI-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethyl)anilino]-2-(4-hydroxypiperidin-1-yl)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)CCN1C1=NC(NC=2C=C(C(Cl)=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 JZJZFCAXXMAKKI-UHFFFAOYSA-N 0.000 claims 2
- CPRZMZBPXDPGNC-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethyl)anilino]-2-[4-(hydroxymethyl)piperidin-1-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(CO)CCN1C1=NC(NC=2C=C(C(Cl)=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 CPRZMZBPXDPGNC-UHFFFAOYSA-N 0.000 claims 2
- KSKZKZVQBVMQEK-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethyl)anilino]-2-[4-hydroxy-4-(hydroxymethyl)piperidin-1-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(CO)(O)CCN1C1=NC(NC=2C=C(C(Cl)=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 KSKZKZVQBVMQEK-UHFFFAOYSA-N 0.000 claims 2
- JODQUOPUBNKSHE-UHFFFAOYSA-N 8-bromo-2-[4-hydroxy-4-(hydroxymethyl)piperidin-1-yl]-4-(4-phenoxyanilino)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(CO)(O)CCN1C1=NC(NC=2C=CC(OC=3C=CC=CC=3)=CC=2)=C2C(=O)NC=C(Br)C2=N1 JODQUOPUBNKSHE-UHFFFAOYSA-N 0.000 claims 2
- NTSZYEUKFCFCMB-UHFFFAOYSA-N 8-bromo-2-[4-hydroxy-4-(hydroxymethyl)piperidin-1-yl]-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(CO)(O)CCN1C1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=C(Br)C2=N1 NTSZYEUKFCFCMB-UHFFFAOYSA-N 0.000 claims 2
- UHEYBRWETBMFMG-UHFFFAOYSA-N FC(C=1C=C(C=CC=1)NC=1N=CC2=C(N=1)C=CNC2=O)(F)F Chemical compound FC(C=1C=C(C=CC=1)NC=1N=CC2=C(N=1)C=CNC2=O)(F)F UHEYBRWETBMFMG-UHFFFAOYSA-N 0.000 claims 2
- 108010020246 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 Proteins 0.000 claims 2
- 102100032693 Leucine-rich repeat serine/threonine-protein kinase 2 Human genes 0.000 claims 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000005422 alkyl sulfonamido group Chemical group 0.000 claims 2
- 150000001408 amides Chemical class 0.000 claims 2
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 125000004193 piperazinyl group Chemical group 0.000 claims 2
- 125000003386 piperidinyl group Chemical group 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 1
- XTFIVUDBNACUBN-UHFFFAOYSA-N 1,3,5-trinitro-1,3,5-triazinane Chemical compound [O-][N+](=O)N1CN([N+]([O-])=O)CN([N+]([O-])=O)C1 XTFIVUDBNACUBN-UHFFFAOYSA-N 0.000 claims 1
- FQUYSHZXSKYCSY-UHFFFAOYSA-N 1,4-diazepane Chemical compound C1CNCCNC1 FQUYSHZXSKYCSY-UHFFFAOYSA-N 0.000 claims 1
- UWJHLWFLONMNRA-UHFFFAOYSA-N 1-(4-fluorophenyl)-3-[4-[6-methyl-2-(methylamino)-5-oxopyrido[4,3-d]pyrimidin-4-yl]phenyl]urea Chemical compound C1=CN(C)C(=O)C=2C1=NC(NC)=NC=2C(C=C1)=CC=C1NC(=O)NC1=CC=C(F)C=C1 UWJHLWFLONMNRA-UHFFFAOYSA-N 0.000 claims 1
- DNCYBUMDUBHIJZ-UHFFFAOYSA-N 1h-pyrimidin-6-one Chemical compound O=C1C=CN=CN1 DNCYBUMDUBHIJZ-UHFFFAOYSA-N 0.000 claims 1
- KYAOIGFSSJYTAV-UHFFFAOYSA-N 2-(1,3-thiazolidin-3-yl)-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=CC(C(F)(F)F)=CC=C1NC1=NC(N2CSCC2)=NC2=C1C(=O)NC=C2 KYAOIGFSSJYTAV-UHFFFAOYSA-N 0.000 claims 1
- FWILRSIFEDCGFF-UHFFFAOYSA-N 2-(1,4-diazepan-1-yl)-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1=CC(C(F)(F)F)=CC=C1NC1=NC(N2CCNCCC2)=NC2=C1C(=O)NC=C2 FWILRSIFEDCGFF-UHFFFAOYSA-N 0.000 claims 1
- QTGNPLDYSBDSBP-UHFFFAOYSA-N 2-(2-morpholin-4-ylethoxy)-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound FC(F)(F)C1=CC=CC(NC=2C=3C(=O)NC=CC=3N=C(OCCN3CCOCC3)N=2)=C1 QTGNPLDYSBDSBP-UHFFFAOYSA-N 0.000 claims 1
- ZIFLUDXWFHTTET-UHFFFAOYSA-N 2-(2-morpholin-4-ylethylamino)-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound FC(F)(F)C1=CC=CC(NC=2C=3C(=O)NC=CC=3N=C(NCCN3CCOCC3)N=2)=C1 ZIFLUDXWFHTTET-UHFFFAOYSA-N 0.000 claims 1
- RYGGCIBGKFDTSD-UHFFFAOYSA-N 2-(3,4-dihydro-1h-isoquinolin-2-yl)-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound FC(F)(F)C1=CC=CC(NC=2C=3C(=O)NC=CC=3N=C(N=2)N2CC3=CC=CC=C3CC2)=C1 RYGGCIBGKFDTSD-UHFFFAOYSA-N 0.000 claims 1
- FPMHBUIAXFBVCH-UHFFFAOYSA-N 2-(3,4-dihydro-1h-isoquinolin-2-yl)-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=CC(C(F)(F)F)=CC=C1NC1=NC(N2CC3=CC=CC=C3CC2)=NC2=C1C(=O)NC=C2 FPMHBUIAXFBVCH-UHFFFAOYSA-N 0.000 claims 1
- HKRSXWHJGCIZMY-UHFFFAOYSA-N 2-(4-acetylpiperazin-1-yl)-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CN(C(=O)C)CCN1C1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 HKRSXWHJGCIZMY-UHFFFAOYSA-N 0.000 claims 1
- VHLBUISSYVNERJ-UHFFFAOYSA-N 2-(4-aminopiperidin-1-yl)-4-(3,5-dimethoxyanilino)-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.COC1=CC(OC)=CC(NC=2C=3C(=O)NC=CC=3N=C(N=2)N2CCC(N)CC2)=C1 VHLBUISSYVNERJ-UHFFFAOYSA-N 0.000 claims 1
- CTTDFQUPWARXKU-UHFFFAOYSA-N 2-(4-aminopiperidin-1-yl)-4-(3-methylanilino)-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.CC1=CC=CC(NC=2C=3C(=O)NC=CC=3N=C(N=2)N2CCC(N)CC2)=C1 CTTDFQUPWARXKU-UHFFFAOYSA-N 0.000 claims 1
- IDTFWKPHMCIKHZ-UHFFFAOYSA-N 2-(4-aminopiperidin-1-yl)-4-(4-bromoanilino)-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1CC(N)CCN1C1=NC(NC=2C=CC(Br)=CC=2)=C2C(=O)NC=CC2=N1 IDTFWKPHMCIKHZ-UHFFFAOYSA-N 0.000 claims 1
- XODWAOQPSCMAOU-UHFFFAOYSA-N 2-(4-aminopiperidin-1-yl)-4-[3,5-bis(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1CC(N)CCN1C1=NC(NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C2C(=O)NC=CC2=N1 XODWAOQPSCMAOU-UHFFFAOYSA-N 0.000 claims 1
- WNJNFLHBUDVBNS-UHFFFAOYSA-N 2-(4-aminopiperidin-1-yl)-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1CC(N)CCN1C1=NC(NC=2C=CC(=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 WNJNFLHBUDVBNS-UHFFFAOYSA-N 0.000 claims 1
- CDJAGGGPGBCHHI-UHFFFAOYSA-N 2-(4-ethylpiperazin-1-yl)-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CN(CC)CCN1C1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 CDJAGGGPGBCHHI-UHFFFAOYSA-N 0.000 claims 1
- UVOUXMCXXRXJSF-UHFFFAOYSA-N 2-(4-hydroxypiperidin-1-yl)-4-(3-methylanilino)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound CC1=CC=CC(NC=2C=3C(=O)NC=CC=3N=C(N=2)N2CCC(O)CC2)=C1 UVOUXMCXXRXJSF-UHFFFAOYSA-N 0.000 claims 1
- KWTXYVYFLMWPFD-UHFFFAOYSA-N 2-(4-hydroxypiperidin-1-yl)-4-(3-methylsulfonylanilino)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound CS(=O)(=O)C1=CC=CC(NC=2C=3C(=O)NC=CC=3N=C(N=2)N2CCC(O)CC2)=C1 KWTXYVYFLMWPFD-UHFFFAOYSA-N 0.000 claims 1
- JELXZLATVQEDBD-UHFFFAOYSA-N 2-(4-hydroxypiperidin-1-yl)-4-(3h-indol-2-ylamino)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)CCN1C1=NC(NC=2CC3=CC=CC=C3N=2)=C2C(=O)NC=CC2=N1 JELXZLATVQEDBD-UHFFFAOYSA-N 0.000 claims 1
- KHJMBIAHNUWJPW-UHFFFAOYSA-N 2-(4-hydroxypiperidin-1-yl)-4-(4-morpholin-4-ylanilino)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)CCN1C1=NC(NC=2C=CC(=CC=2)N2CCOCC2)=C2C(=O)NC=CC2=N1 KHJMBIAHNUWJPW-UHFFFAOYSA-N 0.000 claims 1
- QARVXQLIWISRLB-UHFFFAOYSA-N 2-(4-hydroxypiperidin-1-yl)-4-(naphthalen-2-ylamino)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)CCN1C1=NC(NC=2C=C3C=CC=CC3=CC=2)=C2C(=O)NC=CC2=N1 QARVXQLIWISRLB-UHFFFAOYSA-N 0.000 claims 1
- WVGBQVFMWIUGHD-UHFFFAOYSA-N 2-(4-hydroxypiperidin-1-yl)-4-(quinolin-5-ylamino)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)CCN1C1=NC(NC=2C3=CC=CN=C3C=CC=2)=C2C(=O)NC=CC2=N1 WVGBQVFMWIUGHD-UHFFFAOYSA-N 0.000 claims 1
- KESYUFNFYLJZHN-UHFFFAOYSA-N 2-(4-hydroxypiperidin-1-yl)-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)CCN1C1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 KESYUFNFYLJZHN-UHFFFAOYSA-N 0.000 claims 1
- KQMDVPOCKULZAI-UHFFFAOYSA-N 2-(4-hydroxypiperidin-1-yl)-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)CCN1C1=NC(NC=2C=CC(=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 KQMDVPOCKULZAI-UHFFFAOYSA-N 0.000 claims 1
- JTLACETWTOHYDD-UHFFFAOYSA-N 2-(4-hydroxypiperidin-1-yl)-4-[4-morpholin-4-yl-3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)CCN1C1=NC(NC=2C=C(C(N3CCOCC3)=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 JTLACETWTOHYDD-UHFFFAOYSA-N 0.000 claims 1
- PGJSLHCHYBJFLW-UHFFFAOYSA-N 2-(4-hydroxypiperidin-1-yl)-6-methyl-4-[3-(trifluoromethyl)anilino]pyrido[4,3-d]pyrimidin-5-one Chemical compound C=12C(=O)N(C)C=CC2=NC(N2CCC(O)CC2)=NC=1NC1=CC=CC(C(F)(F)F)=C1 PGJSLHCHYBJFLW-UHFFFAOYSA-N 0.000 claims 1
- IDARVBHTOBSLNW-UHFFFAOYSA-N 2-(4-hydroxypiperidin-1-yl)-8-iodo-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)CCN1C1=NC(NC=2C=CC(=CC=2)C(F)(F)F)=C2C(=O)NC=C(I)C2=N1 IDARVBHTOBSLNW-UHFFFAOYSA-N 0.000 claims 1
- MSUQSRBCACNYNL-UHFFFAOYSA-N 2-(4-methylpiperazin-1-yl)-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CN(C)CCN1C1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 MSUQSRBCACNYNL-UHFFFAOYSA-N 0.000 claims 1
- POBOUSOKEDDROE-UHFFFAOYSA-N 2-(4-methylsulfonylpiperazin-1-yl)-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CN(S(=O)(=O)C)CCN1C1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 POBOUSOKEDDROE-UHFFFAOYSA-N 0.000 claims 1
- SLIFFGBDMBSXJS-UHFFFAOYSA-N 2-(4-morpholin-4-ylpiperidin-1-yl)-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound FC(F)(F)C1=CC=CC(NC=2C=3C(=O)NC=CC=3N=C(N=2)N2CCC(CC2)N2CCOCC2)=C1 SLIFFGBDMBSXJS-UHFFFAOYSA-N 0.000 claims 1
- PWIFFMFHVJEXQU-UHFFFAOYSA-N 2-(4-oxopiperidin-1-yl)-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound FC(F)(F)C1=CC=CC(NC=2C=3C(=O)NC=CC=3N=C(N=2)N2CCC(=O)CC2)=C1 PWIFFMFHVJEXQU-UHFFFAOYSA-N 0.000 claims 1
- YUBHQYQTDBUAQD-UHFFFAOYSA-N 2-(benzylamino)-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=CC(C(F)(F)F)=CC=C1NC1=NC(NCC=2C=CC=CC=2)=NC2=C1C(=O)NC=C2 YUBHQYQTDBUAQD-UHFFFAOYSA-N 0.000 claims 1
- LRAWZXZQTIFBBO-UHFFFAOYSA-N 2-(cyclohexylamino)-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=CC(C(F)(F)F)=CC=C1NC1=NC(NC2CCCCC2)=NC2=C1C(=O)NC=C2 LRAWZXZQTIFBBO-UHFFFAOYSA-N 0.000 claims 1
- NFXNFOBESPZLIF-UHFFFAOYSA-N 2-(cyclopentylamino)-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=CC(C(F)(F)F)=CC=C1NC1=NC(NC2CCCC2)=NC2=C1C(=O)NC=C2 NFXNFOBESPZLIF-UHFFFAOYSA-N 0.000 claims 1
- GBNJUKNPMXFOIP-UHFFFAOYSA-N 2-(morpholin-4-ylamino)-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound FC(F)(F)C1=CC=CC(NC=2C=3C(=O)NC=CC=3N=C(NN3CCOCC3)N=2)=C1 GBNJUKNPMXFOIP-UHFFFAOYSA-N 0.000 claims 1
- GZQRNZHWNGBFTE-UHFFFAOYSA-N 2-(oxan-4-ylamino)-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=CC(C(F)(F)F)=CC=C1NC1=NC(NC2CCOCC2)=NC2=C1C(=O)NC=C2 GZQRNZHWNGBFTE-UHFFFAOYSA-N 0.000 claims 1
- IDUZXVUEBHOHSS-UHFFFAOYSA-N 2-(oxan-4-ylmethylamino)-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=CC(C(F)(F)F)=CC=C1NC1=NC(NCC2CCOCC2)=NC2=C1C(=O)NC=C2 IDUZXVUEBHOHSS-UHFFFAOYSA-N 0.000 claims 1
- VIXSLIFGVGYDEZ-UHFFFAOYSA-N 2-(piperidin-4-ylamino)-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1=CC(C(F)(F)F)=CC=C1NC1=NC(NC2CCNCC2)=NC2=C1C(=O)NC=C2 VIXSLIFGVGYDEZ-UHFFFAOYSA-N 0.000 claims 1
- POTLEFZPCQTIFZ-UHFFFAOYSA-N 2-(piperidin-4-ylmethylamino)-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1=CC(C(F)(F)F)=CC=C1NC1=NC(NCC2CCNCC2)=NC2=C1C(=O)NC=C2 POTLEFZPCQTIFZ-UHFFFAOYSA-N 0.000 claims 1
- GYRRMTWUWWPQHL-UHFFFAOYSA-N 2-[(1-methylpiperidin-4-yl)methylamino]-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CN(C)CCC1CNC1=NC(NC=2C=CC(=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 GYRRMTWUWWPQHL-UHFFFAOYSA-N 0.000 claims 1
- BTCUWBIMQWZONX-UHFFFAOYSA-N 2-[(1-propan-2-ylpiperidin-4-yl)methylamino]-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CN(C(C)C)CCC1CNC1=NC(NC=2C=CC(=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 BTCUWBIMQWZONX-UHFFFAOYSA-N 0.000 claims 1
- JXABSHYWZNDLJL-UHFFFAOYSA-N 2-[(2-aminophenyl)methylamino]-4-(4-morpholin-4-ylanilino)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound NC1=CC=CC=C1CNC1=NC(NC=2C=CC(=CC=2)N2CCOCC2)=C2C(=O)NC=CC2=N1 JXABSHYWZNDLJL-UHFFFAOYSA-N 0.000 claims 1
- UTJNZILSYJOSJM-UHFFFAOYSA-N 2-[(2-aminophenyl)methylamino]-4-[3,5-bis(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound NC1=CC=CC=C1CNC1=NC(NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C2C(=O)NC=CC2=N1 UTJNZILSYJOSJM-UHFFFAOYSA-N 0.000 claims 1
- CAYBJNSSLBJENW-UHFFFAOYSA-N 2-[(3-aminocyclohexyl)amino]-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1C(N)CCCC1NC1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 CAYBJNSSLBJENW-UHFFFAOYSA-N 0.000 claims 1
- ASXFHCYHOZVKPF-RFVHGSKJSA-N 2-[(3r)-3-aminopyrrolidin-1-yl]-4-(4-bromoanilino)-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1[C@H](N)CCN1C1=NC(NC=2C=CC(Br)=CC=2)=C2C(=O)NC=CC2=N1 ASXFHCYHOZVKPF-RFVHGSKJSA-N 0.000 claims 1
- MSLUVFDCXLKRLI-RFVHGSKJSA-N 2-[(3r)-3-aminopyrrolidin-1-yl]-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1[C@H](N)CCN1C1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 MSLUVFDCXLKRLI-RFVHGSKJSA-N 0.000 claims 1
- SBCIJEYGQIUIFH-PFEQFJNWSA-N 2-[(3r)-3-aminopyrrolidin-1-yl]-8-bromo-4-(4-phenoxyanilino)-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1[C@H](N)CCN1C1=NC(NC=2C=CC(OC=3C=CC=CC=3)=CC=2)=C2C(=O)NC=C(Br)C2=N1 SBCIJEYGQIUIFH-PFEQFJNWSA-N 0.000 claims 1
- NFEMRONPIKCMSD-GFCCVEGCSA-N 2-[(3r)-3-hydroxypyrrolidin-1-yl]-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1[C@H](O)CCN1C1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 NFEMRONPIKCMSD-GFCCVEGCSA-N 0.000 claims 1
- ASXFHCYHOZVKPF-MERQFXBCSA-N 2-[(3s)-3-aminopyrrolidin-1-yl]-4-(4-bromoanilino)-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1[C@@H](N)CCN1C1=NC(NC=2C=CC(Br)=CC=2)=C2C(=O)NC=CC2=N1 ASXFHCYHOZVKPF-MERQFXBCSA-N 0.000 claims 1
- DJANDTGEFFLMIW-NSHDSACASA-N 2-[(3s)-3-aminopyrrolidin-1-yl]-4-(4-methylsulfonylanilino)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC(N2C[C@@H](N)CC2)=NC2=C1C(=O)NC=C2 DJANDTGEFFLMIW-NSHDSACASA-N 0.000 claims 1
- MSLUVFDCXLKRLI-MERQFXBCSA-N 2-[(3s)-3-aminopyrrolidin-1-yl]-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1[C@@H](N)CCN1C1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 MSLUVFDCXLKRLI-MERQFXBCSA-N 0.000 claims 1
- NFEMRONPIKCMSD-LBPRGKRZSA-N 2-[(3s)-3-hydroxypyrrolidin-1-yl]-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1[C@@H](O)CCN1C1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 NFEMRONPIKCMSD-LBPRGKRZSA-N 0.000 claims 1
- OBZRMOWKWQWKIC-UHFFFAOYSA-N 2-[(4-fluorophenyl)methylamino]-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=CC(F)=CC=C1CNC1=NC(NC=2C=CC(=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 OBZRMOWKWQWKIC-UHFFFAOYSA-N 0.000 claims 1
- UOOIBWYRUJLYBE-UHFFFAOYSA-N 2-[(4-methyl-1,3-thiazol-2-yl)amino]-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound CC1=CSC(NC=2N=C3C(C(NC=C3)=O)=C(NC=3C=CC(=CC=3)C(F)(F)F)N=2)=N1 UOOIBWYRUJLYBE-UHFFFAOYSA-N 0.000 claims 1
- OTMJEVVBJMCAOM-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CN(CCO)CCN1C1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 OTMJEVVBJMCAOM-UHFFFAOYSA-N 0.000 claims 1
- NKFZAYZMKQBTRQ-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CN(CCO)CCN1C1=NC(NC=2C=CC(=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 NKFZAYZMKQBTRQ-UHFFFAOYSA-N 0.000 claims 1
- MILYKUXQFBBWIK-UHFFFAOYSA-N 2-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1C(N=C1C=2C(NC=C1)=O)=NC=2NC1=CC=CC(C(F)(F)F)=C1 MILYKUXQFBBWIK-UHFFFAOYSA-N 0.000 claims 1
- DTASLHOBQHVENX-UHFFFAOYSA-N 2-[4-(hydroxymethyl)piperidin-1-yl]-4-(4-methoxyphenyl)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=CC(OC)=CC=C1C1=NC(N2CCC(CO)CC2)=NC2=C1C(=O)NC=C2 DTASLHOBQHVENX-UHFFFAOYSA-N 0.000 claims 1
- QKGWFBXDEBODGG-UHFFFAOYSA-N 2-[4-(hydroxymethyl)piperidin-1-yl]-4-(4-morpholin-4-ylanilino)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(CO)CCN1C1=NC(NC=2C=CC(=CC=2)N2CCOCC2)=C2C(=O)NC=CC2=N1 QKGWFBXDEBODGG-UHFFFAOYSA-N 0.000 claims 1
- CKCDTBZLELPNDH-UHFFFAOYSA-N 2-[4-(hydroxymethyl)piperidin-1-yl]-4-[(4-sulfonylcyclohexa-1,5-dien-1-yl)amino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(CO)CCN1C1=NC(NC=2C=CC(CC=2)=S(=O)=O)=C2C(=O)NC=CC2=N1 CKCDTBZLELPNDH-UHFFFAOYSA-N 0.000 claims 1
- WEADIXMHILCWBB-UHFFFAOYSA-N 2-[4-(hydroxymethyl)piperidin-1-yl]-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(CO)CCN1C1=NC(NC=2C=CC(=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 WEADIXMHILCWBB-UHFFFAOYSA-N 0.000 claims 1
- HJALJFXWLMCXST-XFULWGLBSA-N 2-[4-[(3r)-3-aminopyrrolidin-1-yl]piperidin-1-yl]-4-(3-bromoanilino)-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1[C@H](N)CCN1C1CCN(C=2N=C3C(C(NC=C3)=O)=C(NC=3C=C(Br)C=CC=3)N=2)CC1 HJALJFXWLMCXST-XFULWGLBSA-N 0.000 claims 1
- XYAAXXARNQURJH-UHFFFAOYSA-N 2-[4-[(dimethylamino)methyl]piperidin-1-yl]-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(CN(C)C)CCN1C1=NC(NC=2C=CC(=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 XYAAXXARNQURJH-UHFFFAOYSA-N 0.000 claims 1
- RXEITYPUKYENPJ-UHFFFAOYSA-N 2-[4-[4-(2-hydroxyethyl)piperazine-1-carbonyl]piperidin-1-yl]-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CN(CCO)CCN1C(=O)C1CCN(C=2N=C3C(C(NC=C3)=O)=C(NC=3C=CC(=CC=3)C(F)(F)F)N=2)CC1 RXEITYPUKYENPJ-UHFFFAOYSA-N 0.000 claims 1
- JDTWINODLBBVLB-UHFFFAOYSA-N 2-[4-hydroxy-4-(hydroxymethyl)piperidin-1-yl]-4-[3-methoxy-5-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound FC(F)(F)C1=CC(OC)=CC(NC=2C=3C(=O)NC=CC=3N=C(N=2)N2CCC(O)(CO)CC2)=C1 JDTWINODLBBVLB-UHFFFAOYSA-N 0.000 claims 1
- UJSQIHFORUUISG-NVXWUHKLSA-N 2-[[(1r,2r)-2-(dimethylamino)cyclohexyl]amino]-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound CN(C)[C@@H]1CCCC[C@H]1NC1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 UJSQIHFORUUISG-NVXWUHKLSA-N 0.000 claims 1
- IIWBHGOCHDWWKA-QZTJIDSGSA-N 2-[[(1r,2r)-2-aminocyclohexyl]amino]-4-(4-morpholin-4-ylanilino)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound N[C@@H]1CCCC[C@H]1NC1=NC(NC=2C=CC(=CC=2)N2CCOCC2)=C2C(=O)NC=CC2=N1 IIWBHGOCHDWWKA-QZTJIDSGSA-N 0.000 claims 1
- VLGXRXNLZVPHLJ-TZMCWYRMSA-N 2-[[(1r,2r)-2-aminocyclohexyl]amino]-4-[2-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound N[C@@H]1CCCC[C@H]1NC1=NC(NC=2C(=CC=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 VLGXRXNLZVPHLJ-TZMCWYRMSA-N 0.000 claims 1
- BXLDLSUMOAPBBW-ZIAGYGMSSA-N 2-[[(1r,2r)-2-aminocyclohexyl]amino]-4-[3,5-bis(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound N[C@@H]1CCCC[C@H]1NC1=NC(NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C2C(=O)NC=CC2=N1 BXLDLSUMOAPBBW-ZIAGYGMSSA-N 0.000 claims 1
- IIWBHGOCHDWWKA-ZWKOTPCHSA-N 2-[[(1r,2s)-2-aminocyclohexyl]amino]-4-(4-morpholin-4-ylanilino)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound N[C@H]1CCCC[C@H]1NC1=NC(NC=2C=CC(=CC=2)N2CCOCC2)=C2C(=O)NC=CC2=N1 IIWBHGOCHDWWKA-ZWKOTPCHSA-N 0.000 claims 1
- VLGXRXNLZVPHLJ-GXTWGEPZSA-N 2-[[(1r,2s)-2-aminocyclohexyl]amino]-4-[2-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound N[C@H]1CCCC[C@H]1NC1=NC(NC=2C(=CC=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 VLGXRXNLZVPHLJ-GXTWGEPZSA-N 0.000 claims 1
- OSAVMYCIMXJRKW-UONOGXRCSA-N 2-[[(1r,2s)-2-aminocyclohexyl]amino]-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound N[C@H]1CCCC[C@H]1NC1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 OSAVMYCIMXJRKW-UONOGXRCSA-N 0.000 claims 1
- JJPLYNYZFBRALQ-LBPRGKRZSA-N 2-[[(1s)-1-(4-fluorophenyl)ethyl]amino]-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound N([C@@H](C)C=1C=CC(F)=CC=1)C(N=C1C=2C(NC=C1)=O)=NC=2NC1=CC=C(C(F)(F)F)C=C1 JJPLYNYZFBRALQ-LBPRGKRZSA-N 0.000 claims 1
- VRHHTANOBXGUHG-ZDUSSCGKSA-N 2-[[(1s)-1-cyclohexylethyl]amino]-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound N([C@@H](C)C1CCCCC1)C(N=C1C=2C(NC=C1)=O)=NC=2NC1=CC=C(C(F)(F)F)C=C1 VRHHTANOBXGUHG-ZDUSSCGKSA-N 0.000 claims 1
- OSAVMYCIMXJRKW-KGLIPLIRSA-N 2-[[(1s,2r)-2-aminocyclohexyl]amino]-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound N[C@@H]1CCCC[C@@H]1NC1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 OSAVMYCIMXJRKW-KGLIPLIRSA-N 0.000 claims 1
- KMLALGDWMKLFDA-KGLIPLIRSA-N 2-[[(1s,2r)-2-aminocyclohexyl]amino]-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound N[C@@H]1CCCC[C@@H]1NC1=NC(NC=2C=CC(=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 KMLALGDWMKLFDA-KGLIPLIRSA-N 0.000 claims 1
- UNQUCSFHEQTPGA-FPOVZHCZSA-N 2-[[(1s,2s)-2-(benzenesulfonyl)cyclohexyl]amino]-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound FC(F)(F)C1=CC=CC(NC=2C=3C(=O)NC=CC=3N=C(N[C@@H]3[C@H](CCCC3)S(=O)(=O)C=3C=CC=CC=3)N=2)=C1 UNQUCSFHEQTPGA-FPOVZHCZSA-N 0.000 claims 1
- SHGLKXHQNKGRJA-QGZVFWFLSA-N 2-[[(2r)-1-hydroxy-3-phenylpropan-2-yl]amino]-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C([C@H](CO)NC=1N=C2C(C(NC=C2)=O)=C(NC=2C=C(C=CC=2)C(F)(F)F)N=1)C1=CC=CC=C1 SHGLKXHQNKGRJA-QGZVFWFLSA-N 0.000 claims 1
- SHGLKXHQNKGRJA-KRWDZBQOSA-N 2-[[(2s)-1-hydroxy-3-phenylpropan-2-yl]amino]-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C([C@@H](CO)NC=1N=C2C(C(NC=C2)=O)=C(NC=2C=C(C=CC=2)C(F)(F)F)N=1)C1=CC=CC=C1 SHGLKXHQNKGRJA-KRWDZBQOSA-N 0.000 claims 1
- QZBIZRJBLYHGDZ-CYBMUJFWSA-N 2-[[(3r)-1-methylpyrrolidin-3-yl]amino]-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1N(C)CC[C@H]1NC1=NC(NC=2C=CC(=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 QZBIZRJBLYHGDZ-CYBMUJFWSA-N 0.000 claims 1
- QUMZGSXIXOQQAD-OAHLLOKOSA-N 2-[[(3r)-1-propan-2-ylpyrrolidin-3-yl]amino]-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1N(C(C)C)CC[C@H]1NC1=NC(NC=2C=CC(=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 QUMZGSXIXOQQAD-OAHLLOKOSA-N 0.000 claims 1
- JDYUEUKXGIDUOJ-UTONKHPSSA-N 2-[[(3r)-pyrrolidin-3-yl]amino]-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1=CC(C(F)(F)F)=CC=C1NC1=NC(N[C@H]2CNCC2)=NC2=C1C(=O)NC=C2 JDYUEUKXGIDUOJ-UTONKHPSSA-N 0.000 claims 1
- JPOIAFHHRCTYJF-ZDUSSCGKSA-N 2-[[(3s)-1-methylsulfonylpyrrolidin-3-yl]amino]-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1N(S(=O)(=O)C)CC[C@@H]1NC1=NC(NC=2C=CC(=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 JPOIAFHHRCTYJF-ZDUSSCGKSA-N 0.000 claims 1
- GJQUJKQDZYZNMN-UHFFFAOYSA-N 2-[benzyl(methyl)amino]-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound N=1C(NC=2C=CC(=CC=2)C(F)(F)F)=C(C(NC=C2)=O)C2=NC=1N(C)CC1=CC=CC=C1 GJQUJKQDZYZNMN-UHFFFAOYSA-N 0.000 claims 1
- WSQGOJYEEOVZQH-UHFFFAOYSA-N 2-amino-4-anilino-6-methylpyrido[4,3-d]pyrimidin-5-one Chemical compound C=12C(=O)N(C)C=CC2=NC(N)=NC=1NC1=CC=CC=C1 WSQGOJYEEOVZQH-UHFFFAOYSA-N 0.000 claims 1
- FGLRBTCUPOMJJG-UHFFFAOYSA-N 2-morpholin-4-yl-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=CC(C(F)(F)F)=CC=C1NC1=NC(N2CCOCC2)=NC2=C1C(=O)NC=C2 FGLRBTCUPOMJJG-UHFFFAOYSA-N 0.000 claims 1
- REJQTHMJKPOCDU-UHFFFAOYSA-N 2-piperidin-1-yl-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound FC(F)(F)C1=CC=CC(NC=2C=3C(=O)NC=CC=3N=C(N=2)N2CCCCC2)=C1 REJQTHMJKPOCDU-UHFFFAOYSA-N 0.000 claims 1
- BYZZZQFWQZBMEI-UHFFFAOYSA-N 2-thiomorpholin-4-yl-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound FC(F)(F)C1=CC=CC(NC=2C=3C(=O)NC=CC=3N=C(N=2)N2CCSCC2)=C1 BYZZZQFWQZBMEI-UHFFFAOYSA-N 0.000 claims 1
- ACUARQYGZDUYFT-UHFFFAOYSA-N 4-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-2-(4-hydroxypiperidin-1-yl)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)CCN1C1=NC(NC=2C=C3OCCOC3=CC=2)=C2C(=O)NC=CC2=N1 ACUARQYGZDUYFT-UHFFFAOYSA-N 0.000 claims 1
- RSSYIJWURPLBQN-UHFFFAOYSA-N 4-(3,5-dimethoxyanilino)-2-(4-morpholin-4-ylpiperidin-1-yl)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound COC1=CC(OC)=CC(NC=2C=3C(=O)NC=CC=3N=C(N=2)N2CCC(CC2)N2CCOCC2)=C1 RSSYIJWURPLBQN-UHFFFAOYSA-N 0.000 claims 1
- HYMQJKJTGKNYJU-UHFFFAOYSA-N 4-(3,5-dimethylanilino)-2-[4-hydroxy-4-(hydroxymethyl)piperidin-1-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound CC1=CC(C)=CC(NC=2C=3C(=O)NC=CC=3N=C(N=2)N2CCC(O)(CO)CC2)=C1 HYMQJKJTGKNYJU-UHFFFAOYSA-N 0.000 claims 1
- FZEOMEVLCFDVAV-UHFFFAOYSA-N 4-(3-bromo-4-methoxyanilino)-2-(4-hydroxypiperidin-1-yl)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=C(Br)C(OC)=CC=C1NC1=NC(N2CCC(O)CC2)=NC2=C1C(=O)NC=C2 FZEOMEVLCFDVAV-UHFFFAOYSA-N 0.000 claims 1
- DGOMLXCOAAOJLR-UHFFFAOYSA-N 4-(3-bromoanilino)-2-(3-hydroxypiperidin-1-yl)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1C(O)CCCN1C1=NC(NC=2C=C(Br)C=CC=2)=C2C(=O)NC=CC2=N1 DGOMLXCOAAOJLR-UHFFFAOYSA-N 0.000 claims 1
- MRHIZQLDYBWLOB-UHFFFAOYSA-N 4-(3-bromoanilino)-2-(4-hydroxypiperidin-1-yl)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)CCN1C1=NC(NC=2C=C(Br)C=CC=2)=C2C(=O)NC=CC2=N1 MRHIZQLDYBWLOB-UHFFFAOYSA-N 0.000 claims 1
- HPEDAYFDBXGUIF-UHFFFAOYSA-N 4-(4-aminophenyl)-6-methyl-2-(methylamino)pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1=CN(C)C(=O)C=2C1=NC(NC)=NC=2C1=CC=C(N)C=C1 HPEDAYFDBXGUIF-UHFFFAOYSA-N 0.000 claims 1
- YHZBDAOXNIPUAL-UHFFFAOYSA-N 4-(4-bromoanilino)-2-(4-hydroxypiperidin-1-yl)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)CCN1C1=NC(NC=2C=CC(Br)=CC=2)=C2C(=O)NC=CC2=N1 YHZBDAOXNIPUAL-UHFFFAOYSA-N 0.000 claims 1
- JHTKIMHGBRKAPD-UHFFFAOYSA-N 4-(4-chloro-3-methoxyanilino)-2-(4-hydroxypiperidin-1-yl)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=C(Cl)C(OC)=CC(NC=2C=3C(=O)NC=CC=3N=C(N=2)N2CCC(O)CC2)=C1 JHTKIMHGBRKAPD-UHFFFAOYSA-N 0.000 claims 1
- LXAGRYPEAXTXIR-UHFFFAOYSA-N 4-(4-chloro-3-methoxyanilino)-2-[4-hydroxy-4-(hydroxymethyl)piperidin-1-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=C(Cl)C(OC)=CC(NC=2C=3C(=O)NC=CC=3N=C(N=2)N2CCC(O)(CO)CC2)=C1 LXAGRYPEAXTXIR-UHFFFAOYSA-N 0.000 claims 1
- ZPJLTKVTAUQPCV-UHFFFAOYSA-N 4-(4-methoxyphenyl)-6-methyl-2-(methylamino)pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=CN(C)C(=O)C=2C1=NC(NC)=NC=2C1=CC=C(OC)C=C1 ZPJLTKVTAUQPCV-UHFFFAOYSA-N 0.000 claims 1
- ZRSSPJZTVGXCSL-UHFFFAOYSA-N 4-(4-methylsulfonylanilino)-2-(4-morpholin-4-ylpiperidin-1-yl)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC(N2CCC(CC2)N2CCOCC2)=NC2=C1C(=O)NC=C2 ZRSSPJZTVGXCSL-UHFFFAOYSA-N 0.000 claims 1
- ZMNQWWWPHHCWGK-UHFFFAOYSA-N 4-(4-morpholin-4-ylanilino)-2-(piperidin-4-ylmethylamino)-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.N=1C(NC=2C=CC(=CC=2)N2CCOCC2)=C2C(=O)NC=CC2=NC=1NCC1CCNCC1 ZMNQWWWPHHCWGK-UHFFFAOYSA-N 0.000 claims 1
- WZSQNEQVNYZVNO-RSAXXLAASA-N 4-(4-morpholin-4-ylanilino)-2-[[(3s)-pyrrolidin-3-yl]amino]-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.N=1C(NC=2C=CC(=CC=2)N2CCOCC2)=C2C(=O)NC=CC2=NC=1N[C@H]1CCNC1 WZSQNEQVNYZVNO-RSAXXLAASA-N 0.000 claims 1
- VEFMMRDHQDMOOL-NTISSMGPSA-N 4-(n-phenoxyanilino)-2-[[(3s)-pyrrolidin-3-yl]amino]-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.N=1C(N(OC=2C=CC=CC=2)C=2C=CC=CC=2)=C2C(=O)NC=CC2=NC=1N[C@H]1CCNC1 VEFMMRDHQDMOOL-NTISSMGPSA-N 0.000 claims 1
- OCEBMGHYJWAZMQ-UHFFFAOYSA-N 4-[(4-fluorophenyl)methylamino]-6-methyl-2-(methylamino)pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=CN(C)C(=O)C=2C1=NC(NC)=NC=2NCC1=CC=C(F)C=C1 OCEBMGHYJWAZMQ-UHFFFAOYSA-N 0.000 claims 1
- QYJZIFWSAWLVHX-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)anilino]-2-(3-hydroxyazetidin-1-yl)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1C(O)CN1C1=NC(NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C2C(=O)NC=CC2=N1 QYJZIFWSAWLVHX-UHFFFAOYSA-N 0.000 claims 1
- JQECXVPMRYDQGE-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)anilino]-2-(4-hydroxyiminopiperidin-1-yl)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(=NO)CCN1C1=NC(NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C2C(=O)NC=CC2=N1 JQECXVPMRYDQGE-UHFFFAOYSA-N 0.000 claims 1
- PZPFFYMISMLKCX-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)anilino]-2-(4-hydroxypiperidin-1-yl)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)CCN1C1=NC(NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C2C(=O)NC=CC2=N1 PZPFFYMISMLKCX-UHFFFAOYSA-N 0.000 claims 1
- YOIIPHONMHCVGI-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)anilino]-2-(4-methylpiperazin-1-yl)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CN(C)CCN1C1=NC(NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C2C(=O)NC=CC2=N1 YOIIPHONMHCVGI-UHFFFAOYSA-N 0.000 claims 1
- GNCIOXXJJAUYIL-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)anilino]-2-(piperidin-4-ylamino)-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.FC(F)(F)C1=CC(C(F)(F)F)=CC(NC=2C=3C(=O)NC=CC=3N=C(NC3CCNCC3)N=2)=C1 GNCIOXXJJAUYIL-UHFFFAOYSA-N 0.000 claims 1
- UHNUCLGIBOVGMK-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)anilino]-2-[(1-methylpiperidin-4-yl)amino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CN(C)CCC1NC1=NC(NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C2C(=O)NC=CC2=N1 UHNUCLGIBOVGMK-UHFFFAOYSA-N 0.000 claims 1
- PTKWCXGLEZSJEM-GFCCVEGCSA-N 4-[3,5-bis(trifluoromethyl)anilino]-2-[(3r)-3-hydroxypyrrolidin-1-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1[C@H](O)CCN1C1=NC(NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C2C(=O)NC=CC2=N1 PTKWCXGLEZSJEM-GFCCVEGCSA-N 0.000 claims 1
- WNXGFVVEZDSYRS-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)anilino]-2-[4-(2-hydroxyethyl)piperazin-1-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CN(CCO)CCN1C1=NC(NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C2C(=O)NC=CC2=N1 WNXGFVVEZDSYRS-UHFFFAOYSA-N 0.000 claims 1
- POSGYHLWEGWYBS-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)anilino]-2-[4-(2-hydroxyethyl)piperidin-1-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(CCO)CCN1C1=NC(NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C2C(=O)NC=CC2=N1 POSGYHLWEGWYBS-UHFFFAOYSA-N 0.000 claims 1
- WBJOTKFIPMATGB-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)anilino]-2-[4-(dimethylamino)piperidin-1-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(N(C)C)CCN1C1=NC(NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C2C(=O)NC=CC2=N1 WBJOTKFIPMATGB-UHFFFAOYSA-N 0.000 claims 1
- QBHHOUDGSJQPJA-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)anilino]-2-[4-(hydroxymethyl)piperidin-1-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(CO)CCN1C1=NC(NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C2C(=O)NC=CC2=N1 QBHHOUDGSJQPJA-UHFFFAOYSA-N 0.000 claims 1
- KYWGBJQYXMEPSU-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)anilino]-2-[4-hydroxy-4-(hydroxymethyl)piperidin-1-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(CO)(O)CCN1C1=NC(NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C2C(=O)NC=CC2=N1 KYWGBJQYXMEPSU-UHFFFAOYSA-N 0.000 claims 1
- MWSLGAZSVYHJIW-LBPRGKRZSA-N 4-[3,5-bis(trifluoromethyl)anilino]-2-[[(3s)-1-methylpyrrolidin-3-yl]amino]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1N(C)CC[C@@H]1NC1=NC(NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C2C(=O)NC=CC2=N1 MWSLGAZSVYHJIW-LBPRGKRZSA-N 0.000 claims 1
- YCLVXMJEBOAGBZ-MERQFXBCSA-N 4-[3,5-bis(trifluoromethyl)anilino]-2-[[(3s)-pyrrolidin-3-yl]amino]-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.FC(F)(F)C1=CC(C(F)(F)F)=CC(NC=2C=3C(=O)NC=CC=3N=C(N[C@@H]3CNCC3)N=2)=C1 YCLVXMJEBOAGBZ-MERQFXBCSA-N 0.000 claims 1
- OTDYZAHBMXZWHW-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)anilino]-2-morpholin-4-yl-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(NC=2C=3C(=O)NC=CC=3N=C(N=2)N2CCOCC2)=C1 OTDYZAHBMXZWHW-UHFFFAOYSA-N 0.000 claims 1
- PVHKXJCINQXTHN-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)anilino]-2-piperazin-1-yl-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.FC(F)(F)C1=CC(C(F)(F)F)=CC(NC=2C=3C(=O)NC=CC=3N=C(N=2)N2CCNCC2)=C1 PVHKXJCINQXTHN-UHFFFAOYSA-N 0.000 claims 1
- OPTOPZULGIQWGM-UHFFFAOYSA-N 4-[3-bromo-5-(trifluoromethyl)anilino]-2-(4-hydroxypiperidin-1-yl)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)CCN1C1=NC(NC=2C=C(C=C(Br)C=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 OPTOPZULGIQWGM-UHFFFAOYSA-N 0.000 claims 1
- JMEGUODDPBGPFR-UHFFFAOYSA-N 4-[3-bromo-5-(trifluoromethyl)anilino]-2-[4-hydroxy-4-(hydroxymethyl)piperidin-1-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(CO)(O)CCN1C1=NC(NC=2C=C(C=C(Br)C=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 JMEGUODDPBGPFR-UHFFFAOYSA-N 0.000 claims 1
- BVSPLCWRSZUHIC-UHFFFAOYSA-N 4-[4-(4-oxidomorpholin-4-ium-4-yl)anilino]-2-(piperidin-4-ylmethylamino)-6h-pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C=1C=C(NC=2C=3C(=O)NC=CC=3N=C(NCC3CCNCC3)N=2)C=CC=1[N+]1([O-])CCOCC1 BVSPLCWRSZUHIC-UHFFFAOYSA-N 0.000 claims 1
- DHDZCBSSTGQGNK-UHFFFAOYSA-N 4-[4-(trifluoromethyl)anilino]-2-[3-(trifluoromethyl)-6,8-dihydro-5h-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CN2C(C(F)(F)F)=NN=C2CN1C(N=C1C=2C(NC=C1)=O)=NC=2NC1=CC=C(C(F)(F)F)C=C1 DHDZCBSSTGQGNK-UHFFFAOYSA-N 0.000 claims 1
- SEPBLTWUGRTPMS-UHFFFAOYSA-N 4-[4-(trifluoromethyl)anilino]-2-[3-[3-(trifluoromethyl)phenyl]-6,7-dihydro-4h-triazolo[1,5-a]pyrazin-5-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=CC(C(F)(F)F)=CC=C1NC1=NC(N2CC3=C(N=NN3CC2)C=2C=C(C=CC=2)C(F)(F)F)=NC2=C1C(=O)NC=C2 SEPBLTWUGRTPMS-UHFFFAOYSA-N 0.000 claims 1
- OTSDYLIWOGPUSE-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethoxy)anilino]-2-(4-hydroxypiperidin-1-yl)-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)CCN1C1=NC(NC=2C=C(OC(F)(F)F)C(Cl)=CC=2)=C2C(=O)NC=CC2=N1 OTSDYLIWOGPUSE-UHFFFAOYSA-N 0.000 claims 1
- OTFJJGWQNNHVKO-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethoxy)anilino]-2-[4-hydroxy-4-(hydroxymethyl)piperidin-1-yl]-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(CO)(O)CCN1C1=NC(NC=2C=C(OC(F)(F)F)C(Cl)=CC=2)=C2C(=O)NC=CC2=N1 OTFJJGWQNNHVKO-UHFFFAOYSA-N 0.000 claims 1
- RASRYSOLZNQFPA-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethyl)anilino]-2-(4-hydroxypiperidin-1-yl)-8-iodo-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(O)CCN1C1=NC(NC=2C=C(C(Cl)=CC=2)C(F)(F)F)=C2C(=O)NC=C(I)C2=N1 RASRYSOLZNQFPA-UHFFFAOYSA-N 0.000 claims 1
- PEFSWMZVSBUHJX-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethyl)anilino]-2-[4-hydroxy-4-(hydroxymethyl)piperidin-1-yl]-8-iodo-6h-pyrido[4,3-d]pyrimidin-5-one Chemical compound C1CC(CO)(O)CCN1C1=NC(NC=2C=C(C(Cl)=CC=2)C(F)(F)F)=C2C(=O)NC=C(I)C2=N1 PEFSWMZVSBUHJX-UHFFFAOYSA-N 0.000 claims 1
- QYEMJKNSSVGDJW-UHFFFAOYSA-N 4-anilino-2-[(4-hydroxycyclohexyl)amino]-6-methylpyrido[4,3-d]pyrimidin-5-one Chemical compound N=1C(NC=2C=CC=CC=2)=C2C(=O)N(C)C=CC2=NC=1NC1CCC(O)CC1 QYEMJKNSSVGDJW-UHFFFAOYSA-N 0.000 claims 1
- OUVXBTJBINCTLH-UHFFFAOYSA-N 4-anilino-2-[(4-methoxyphenyl)methylamino]-6-methylpyrido[4,3-d]pyrimidin-5-one Chemical compound C1=CC(OC)=CC=C1CNC1=NC(NC=2C=CC=CC=2)=C2C(=O)N(C)C=CC2=N1 OUVXBTJBINCTLH-UHFFFAOYSA-N 0.000 claims 1
- GKXNPRVOXCZJMR-UHFFFAOYSA-N 4-anilino-6-methyl-2-(methylamino)pyrido[4,3-d]pyrimidin-5-one Chemical compound C1=CN(C)C(=O)C=2C1=NC(NC)=NC=2NC1=CC=CC=C1 GKXNPRVOXCZJMR-UHFFFAOYSA-N 0.000 claims 1
- JHHKIDZXDFJQPX-UHFFFAOYSA-N 4-anilino-6-methyl-2-[3-(trifluoromethyl)anilino]pyrido[4,3-d]pyrimidin-5-one Chemical compound N=1C(NC=2C=CC=CC=2)=C2C(=O)N(C)C=CC2=NC=1NC1=CC=CC(C(F)(F)F)=C1 JHHKIDZXDFJQPX-UHFFFAOYSA-N 0.000 claims 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 1
- LUJCBGVNNKFMQF-UTONKHPSSA-N 6-[(3r)-3-aminopyrrolidin-1-yl]-4-bromo-8-[4-(trifluoromethyl)anilino]-2h-isoquinolin-1-one;hydrochloride Chemical compound Cl.C1[C@H](N)CCN1C1=CC(NC=2C=CC(=CC=2)C(F)(F)F)=C2C(=O)NC=C(Br)C2=C1 LUJCBGVNNKFMQF-UTONKHPSSA-N 0.000 claims 1
- CWGGUOIZQYASDR-UTONKHPSSA-N 6-[(3r)-3-aminopyrrolidin-1-yl]-4-iodo-8-[4-(trifluoromethyl)anilino]-2h-isoquinolin-1-one;hydrochloride Chemical compound Cl.C1[C@H](N)CCN1C1=CC(NC=2C=CC(=CC=2)C(F)(F)F)=C2C(=O)NC=C(I)C2=C1 CWGGUOIZQYASDR-UTONKHPSSA-N 0.000 claims 1
- LUJCBGVNNKFMQF-YDALLXLXSA-N 6-[(3s)-3-aminopyrrolidin-1-yl]-4-bromo-8-[4-(trifluoromethyl)anilino]-2h-isoquinolin-1-one;hydrochloride Chemical compound Cl.C1[C@@H](N)CCN1C1=CC(NC=2C=CC(=CC=2)C(F)(F)F)=C2C(=O)NC=C(Br)C2=C1 LUJCBGVNNKFMQF-YDALLXLXSA-N 0.000 claims 1
- GOQOJDQHWCTIAD-UHFFFAOYSA-N 6-methyl-2-(methylamino)-4-[4-(piperazine-1-carbonyl)anilino]pyrido[4,3-d]pyrimidin-5-one;hydrochloride Chemical compound Cl.C1=CN(C)C(=O)C=2C1=NC(NC)=NC=2NC(C=C1)=CC=C1C(=O)N1CCNCC1 GOQOJDQHWCTIAD-UHFFFAOYSA-N 0.000 claims 1
- 102100033793 ALK tyrosine kinase receptor Human genes 0.000 claims 1
- 102000004000 Aurora Kinase A Human genes 0.000 claims 1
- 108090000461 Aurora Kinase A Proteins 0.000 claims 1
- 102100025422 Bone morphogenetic protein receptor type-2 Human genes 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 102100037813 Focal adhesion kinase 1 Human genes 0.000 claims 1
- 101000779641 Homo sapiens ALK tyrosine kinase receptor Proteins 0.000 claims 1
- 101000934635 Homo sapiens Bone morphogenetic protein receptor type-2 Proteins 0.000 claims 1
- 101000878536 Homo sapiens Focal adhesion kinase 1 Proteins 0.000 claims 1
- 101001064870 Homo sapiens Lon protease homolog, mitochondrial Proteins 0.000 claims 1
- 101000916644 Homo sapiens Macrophage colony-stimulating factor 1 receptor Proteins 0.000 claims 1
- 101000628949 Homo sapiens Mitogen-activated protein kinase 10 Proteins 0.000 claims 1
- 101000950695 Homo sapiens Mitogen-activated protein kinase 8 Proteins 0.000 claims 1
- 101000950669 Homo sapiens Mitogen-activated protein kinase 9 Proteins 0.000 claims 1
- 101001055085 Homo sapiens Mitogen-activated protein kinase kinase kinase 9 Proteins 0.000 claims 1
- 101000844245 Homo sapiens Non-receptor tyrosine-protein kinase TYK2 Proteins 0.000 claims 1
- 101000878540 Homo sapiens Protein-tyrosine kinase 2-beta Proteins 0.000 claims 1
- 101000579425 Homo sapiens Proto-oncogene tyrosine-protein kinase receptor Ret Proteins 0.000 claims 1
- 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 claims 1
- 101000595531 Homo sapiens Serine/threonine-protein kinase pim-1 Proteins 0.000 claims 1
- 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 claims 1
- 101000934996 Homo sapiens Tyrosine-protein kinase JAK3 Proteins 0.000 claims 1
- 101000604583 Homo sapiens Tyrosine-protein kinase SYK Proteins 0.000 claims 1
- 101000818543 Homo sapiens Tyrosine-protein kinase ZAP-70 Proteins 0.000 claims 1
- 101000807561 Homo sapiens Tyrosine-protein kinase receptor UFO Proteins 0.000 claims 1
- 102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 claims 1
- 102100026931 Mitogen-activated protein kinase 10 Human genes 0.000 claims 1
- 102100037808 Mitogen-activated protein kinase 8 Human genes 0.000 claims 1
- 102100037809 Mitogen-activated protein kinase 9 Human genes 0.000 claims 1
- 102100026888 Mitogen-activated protein kinase kinase kinase 7 Human genes 0.000 claims 1
- 102100026909 Mitogen-activated protein kinase kinase kinase 9 Human genes 0.000 claims 1
- 102100032028 Non-receptor tyrosine-protein kinase TYK2 Human genes 0.000 claims 1
- 102100037787 Protein-tyrosine kinase 2-beta Human genes 0.000 claims 1
- 102100028286 Proto-oncogene tyrosine-protein kinase receptor Ret Human genes 0.000 claims 1
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 claims 1
- 102100026715 Serine/threonine-protein kinase STK11 Human genes 0.000 claims 1
- 101710181599 Serine/threonine-protein kinase STK11 Proteins 0.000 claims 1
- 102100036077 Serine/threonine-protein kinase pim-1 Human genes 0.000 claims 1
- 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 claims 1
- 102100025387 Tyrosine-protein kinase JAK3 Human genes 0.000 claims 1
- 102100038183 Tyrosine-protein kinase SYK Human genes 0.000 claims 1
- 102100021125 Tyrosine-protein kinase ZAP-70 Human genes 0.000 claims 1
- 102100037236 Tyrosine-protein kinase receptor UFO Human genes 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 230000005907 cancer growth Effects 0.000 claims 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 1
- 125000006317 cyclopropyl amino group Chemical group 0.000 claims 1
- 125000005433 dihydrobenzodioxinyl group Chemical group O1C(COC2=C1C=CC=C2)* 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- UUKRJEDNMDWVAP-UHFFFAOYSA-N methoxy(methoxymethylsulfonyl)methane Chemical compound COCS(=O)(=O)COC UUKRJEDNMDWVAP-UHFFFAOYSA-N 0.000 claims 1
- VXLRYWWTKQGUJB-UHFFFAOYSA-N methyl 1-[4-(3,5-dimethoxyanilino)-5-oxo-6h-pyrido[4,3-d]pyrimidin-2-yl]-4-hydroxypiperidine-4-carboxylate Chemical compound C1CC(C(=O)OC)(O)CCN1C1=NC(NC=2C=C(OC)C=C(OC)C=2)=C2C(=O)NC=CC2=N1 VXLRYWWTKQGUJB-UHFFFAOYSA-N 0.000 claims 1
- JSRJNSZKSUJSAV-UHFFFAOYSA-N methyl 1-[4-[3,5-bis(trifluoromethyl)anilino]-5-oxo-6h-pyrido[4,3-d]pyrimidin-2-yl]-4-hydroxypiperidine-4-carboxylate Chemical class C1CC(C(=O)OC)(O)CCN1C1=NC(NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C2C(=O)NC=CC2=N1 JSRJNSZKSUJSAV-UHFFFAOYSA-N 0.000 claims 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 1
- GGULWMGHKRDSKG-CVEARBPZSA-N n-[(1r,2s)-2-[[5-oxo-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-2-yl]amino]cyclohexyl]acetamide Chemical compound CC(=O)N[C@@H]1CCCC[C@@H]1NC1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 GGULWMGHKRDSKG-CVEARBPZSA-N 0.000 claims 1
- JBBUKPHVMIZJEJ-UHFFFAOYSA-N n-[1-[5-oxo-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-2-yl]piperidin-4-yl]cyclopropanesulfonamide Chemical compound C1=CC(C(F)(F)F)=CC=C1NC1=NC(N2CCC(CC2)NS(=O)(=O)C2CC2)=NC2=C1C(=O)NC=C2 JBBUKPHVMIZJEJ-UHFFFAOYSA-N 0.000 claims 1
- SGZCIFYROYSRAS-UHFFFAOYSA-N n-[2-[[[4-(4-methylsulfonylanilino)-5-oxo-6h-pyrido[4,3-d]pyrimidin-2-yl]amino]methyl]phenyl]cyclopropanesulfonamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC(NCC=2C(=CC=CC=2)NS(=O)(=O)C2CC2)=NC2=C1C(=O)NC=C2 SGZCIFYROYSRAS-UHFFFAOYSA-N 0.000 claims 1
- BPOZSCXVJWVZOD-UHFFFAOYSA-N n-[2-[[[4-(4-methylsulfonylanilino)-5-oxo-6h-pyrido[4,3-d]pyrimidin-2-yl]amino]methyl]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC=C1CNC1=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C2C(=O)NC=CC2=N1 BPOZSCXVJWVZOD-UHFFFAOYSA-N 0.000 claims 1
- DGYWFSANQBWXAG-UHFFFAOYSA-N n-[2-[[[4-(4-morpholin-4-ylanilino)-5-oxo-6h-pyrido[4,3-d]pyrimidin-2-yl]amino]methyl]phenyl]cyclopropanesulfonamide Chemical compound N=1C(NC=2C=CC(=CC=2)N2CCOCC2)=C2C(=O)NC=CC2=NC=1NCC1=CC=CC=C1NS(=O)(=O)C1CC1 DGYWFSANQBWXAG-UHFFFAOYSA-N 0.000 claims 1
- ZMKHYFPKDMNKGX-UHFFFAOYSA-N n-[2-[[[4-(4-morpholin-4-ylanilino)-5-oxo-6h-pyrido[4,3-d]pyrimidin-2-yl]amino]methyl]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC=C1CNC1=NC(NC=2C=CC(=CC=2)N2CCOCC2)=C2C(=O)NC=CC2=N1 ZMKHYFPKDMNKGX-UHFFFAOYSA-N 0.000 claims 1
- NTRAFURDIBLQHF-UHFFFAOYSA-N n-[2-[[[5-oxo-4-[3-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-2-yl]amino]methyl]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC=C1CNC1=NC(NC=2C=C(C=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 NTRAFURDIBLQHF-UHFFFAOYSA-N 0.000 claims 1
- HAAFUMYIBQIZEH-UHFFFAOYSA-N n-[2-[[[5-oxo-4-[4-(trifluoromethyl)anilino]-6h-pyrido[4,3-d]pyrimidin-2-yl]amino]methyl]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC=C1CNC1=NC(NC=2C=CC(=CC=2)C(F)(F)F)=C2C(=O)NC=CC2=N1 HAAFUMYIBQIZEH-UHFFFAOYSA-N 0.000 claims 1
- JTSLALYXYSRPGW-UHFFFAOYSA-N n-[5-(4-cyanophenyl)-1h-pyrrolo[2,3-b]pyridin-3-yl]pyridine-3-carboxamide Chemical compound C=1C=CN=CC=1C(=O)NC(C1=C2)=CNC1=NC=C2C1=CC=C(C#N)C=C1 JTSLALYXYSRPGW-UHFFFAOYSA-N 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 150000002923 oximes Chemical class 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 1
- UDJFFSGCRRMVFH-UHFFFAOYSA-N pyrido[2,3-d]pyrimidine Chemical compound N1=CN=CC2=CC=CN=C21 UDJFFSGCRRMVFH-UHFFFAOYSA-N 0.000 claims 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 1
- 230000011664 signaling Effects 0.000 claims 1
- 150000003456 sulfonamides Chemical class 0.000 claims 1
- 108091008743 testicular receptors 4 Proteins 0.000 claims 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 claims 1
- 125000005505 thiomorpholino group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25622209P | 2009-10-29 | 2009-10-29 | |
| US61/256,222 | 2009-10-29 | ||
| PCT/US2010/054853 WO2011053861A1 (en) | 2009-10-29 | 2010-10-29 | Kinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013509438A JP2013509438A (ja) | 2013-03-14 |
| JP2013509438A5 true JP2013509438A5 (https=) | 2014-02-06 |
| JP5993742B2 JP5993742B2 (ja) | 2016-09-14 |
Family
ID=43922599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012537147A Active JP5993742B2 (ja) | 2009-10-29 | 2010-10-29 | キナーゼ阻害剤 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8404677B2 (https=) |
| EP (1) | EP2493313B1 (https=) |
| JP (1) | JP5993742B2 (https=) |
| KR (1) | KR101690358B1 (https=) |
| CN (1) | CN102695416B (https=) |
| BR (1) | BR112012010085B1 (https=) |
| CA (1) | CA2779105C (https=) |
| CL (1) | CL2012001073A1 (https=) |
| EA (1) | EA029273B1 (https=) |
| ES (1) | ES2658290T3 (https=) |
| IL (1) | IL219447A (https=) |
| MX (1) | MX2012004846A (https=) |
| MY (1) | MY173494A (https=) |
| NZ (2) | NZ630860A (https=) |
| SG (1) | SG10201407012XA (https=) |
| TR (1) | TR201802464T4 (https=) |
| WO (1) | WO2011053861A1 (https=) |
| ZA (1) | ZA201203842B (https=) |
Families Citing this family (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ604708A (en) | 2010-05-20 | 2015-05-29 | Array Biopharma Inc | Macrocyclic compounds as trk kinase inhibitors |
| WO2012097479A1 (en) * | 2011-01-21 | 2012-07-26 | Abbott Laboratories | Bicyclic inhibitors of anaphastic lymphoma kinase |
| CN103415516A (zh) * | 2011-01-21 | 2013-11-27 | Abbvie公司 | Alk的双环抑制剂 |
| ES2969977T3 (es) * | 2011-08-23 | 2024-05-23 | Libertas Bio Inc | Compuestos de pirimido-piridazinona y uso de los mismos |
| WO2013125543A1 (ja) * | 2012-02-20 | 2013-08-29 | 武田薬品工業株式会社 | 複素環化合物 |
| CN104271576A (zh) * | 2012-02-23 | 2015-01-07 | 艾伯维公司 | 激酶的吡啶并嘧啶酮抑制剂 |
| EP2828259B1 (en) * | 2012-03-22 | 2018-08-08 | Oscotec, Inc. | Substituted pyridopyrimidine compounds and their use as flt3 inhibitors |
| WO2014001973A1 (en) | 2012-06-29 | 2014-01-03 | Pfizer Inc. | NOVEL 4-(SUBSTITUTED-AMINO)-7H-PYRROLO[2,3-d]PYRIMIDINES AS LRRK2 INHIBITORS |
| ES2618004T3 (es) * | 2012-08-07 | 2017-06-20 | Merck Patent Gmbh | Derivados de piridopirimidina como inhibidores de proteínas quinasas |
| KR20150042256A (ko) * | 2012-08-13 | 2015-04-20 | 노파르티스 아게 | 비장 티로신 키나제 (syk)의 억제제로서의 비시클릭 헤테로아릴 시클로알킬디아민 유도체 |
| CN103664938A (zh) * | 2012-09-12 | 2014-03-26 | 山东亨利医药科技有限责任公司 | 含有嘧啶并环的syk抑制剂 |
| EP2897950A1 (en) | 2012-09-18 | 2015-07-29 | Ziarco Pharma Ltd | 2-(2-aminocyclohexyl)amino-pyrimidine-5-carboxamides as spleen tyrosine kinasei(syk) inhibitors |
| WO2014051653A1 (en) | 2012-09-27 | 2014-04-03 | Portola Pharmaceuticals, Inc. | Bicyclic dihydropyridone kinase inhibitors |
| JP6437452B2 (ja) | 2013-01-14 | 2018-12-12 | インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ | Ｐｉｍキナーゼ阻害剤として有用な二環式芳香族カルボキサミド化合物 |
| RS60244B1 (sr) | 2013-01-15 | 2020-06-30 | Incyte Holdings Corp | Jedinjenja tiazolkarboksamida i piridinkarboksamida korisna kao inhibitori pim kinaze |
| CN104341437A (zh) * | 2013-07-30 | 2015-02-11 | 山东亨利医药科技有限责任公司 | 含有双环基团的syk抑制剂 |
| CN105658653A (zh) | 2013-08-23 | 2016-06-08 | 因赛特公司 | 可用作pim激酶抑制剂的呋喃并-和噻吩并-吡啶甲酰胺化合物 |
| JP6487921B2 (ja) | 2013-12-17 | 2019-03-20 | ファイザー・インク | ＬＲＲＫ２阻害薬としての新規の３，４−二置換−１Ｈ−ピロロ［２，３−ｂ］ピリジンおよび４，５−二置換−７Ｈ−ピロロ［２，３−ｃ］ピリダジン |
| WO2015146928A1 (ja) * | 2014-03-24 | 2015-10-01 | 武田薬品工業株式会社 | 複素環化合物 |
| EP3166637B1 (en) | 2014-07-10 | 2020-01-29 | The J. David Gladstone Institutes | Compositions and methods for treating dengue virus infection |
| WO2016010897A1 (en) | 2014-07-14 | 2016-01-21 | Incyte Corporation | Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors |
| US9580418B2 (en) | 2014-07-14 | 2017-02-28 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors |
| KR20160035411A (ko) * | 2014-09-23 | 2016-03-31 | 주식회사 오스코텍 | LRRK2 (Leucine Rich Repeat Kinase 2) 키나제 억제제로서의 피리도피리미딘 유도체 화합물 |
| WO2016196244A1 (en) | 2015-05-29 | 2016-12-08 | Incyte Corporation | Pyridineamine compounds useful as pim kinase inhibitors |
| KR101845931B1 (ko) * | 2015-06-18 | 2018-04-05 | 한국화학연구원 | 헤테로아릴 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 pi3 키나아제 관련 질환의 예방 또는 치료용 약학적 조성물 |
| WO2016204429A1 (ko) * | 2015-06-18 | 2016-12-22 | 한국화학연구원 | 헤테로아릴 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 pi3 키나아제 관련 질환의 예방 또는 치료용 약학적 조성물. |
| BR112018000808A2 (pt) | 2015-07-16 | 2018-09-04 | Array Biopharma Inc | compostos de pirazolo[1,5-a]piridina substituída como inibidores de ret cinase |
| TWI734699B (zh) | 2015-09-09 | 2021-08-01 | 美商英塞特公司 | Ｐｉｍ激酶抑制劑之鹽 |
| KR102161364B1 (ko) | 2015-09-14 | 2020-09-29 | 화이자 인코포레이티드 | LRRK2 억제제로서 이미다조[4,5-c]퀴놀린 및 이미다조[4,5-c][1,5]나프티리딘 유도체 |
| US9920032B2 (en) | 2015-10-02 | 2018-03-20 | Incyte Corporation | Heterocyclic compounds useful as pim kinase inhibitors |
| AR106830A1 (es) * | 2015-12-04 | 2018-02-21 | Asana Biosciences Llc | Usos de piridazinonas para tratar el cáncer |
| TWI752098B (zh) | 2016-10-10 | 2022-01-11 | 美商亞雷生物製藥股份有限公司 | 作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物 |
| TWI704148B (zh) | 2016-10-10 | 2020-09-11 | 美商亞雷生物製藥股份有限公司 | 作為ｒｅｔ激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物 |
| JP7219218B2 (ja) | 2016-12-22 | 2023-02-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規のベンジルアミノ置換キナゾリンおよびｓｏｓ１阻害剤としての誘導体 |
| WO2018136663A1 (en) | 2017-01-18 | 2018-07-26 | Array Biopharma, Inc. | Ret inhibitors |
| US11168090B2 (en) | 2017-01-18 | 2021-11-09 | Array Biopharma Inc. | Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors |
| JOP20190213A1 (ar) | 2017-03-16 | 2019-09-16 | Array Biopharma Inc | مركبات حلقية ضخمة كمثبطات لكيناز ros1 |
| KR20190140011A (ko) | 2017-04-28 | 2019-12-18 | 아사나 바이오사이언시스 엘엘씨 | 아토피성 피부염을 치료하고, 활성 약학적 성분의 안정성을 개선하기 위한 제형물, 방법, 키트, 및 투여형 |
| CN107194205B (zh) * | 2017-05-31 | 2020-11-24 | 浙江大学 | 具有杀菌活性的jak2激酶抑制剂及其虚拟筛选方法 |
| TWI812649B (zh) | 2017-10-10 | 2023-08-21 | 美商絡速藥業公司 | 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物 |
| TWI791053B (zh) | 2017-10-10 | 2023-02-01 | 美商亞雷生物製藥股份有限公司 | 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物 |
| AR113922A1 (es) | 2017-12-08 | 2020-07-01 | Incyte Corp | Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas |
| RS64167B1 (sr) | 2017-12-21 | 2023-05-31 | Boehringer Ingelheim Int | Benzilamino supstituisani piridopirimidinoni i derivati kao sos1 inhibitori |
| ES2971712T3 (es) | 2017-12-22 | 2024-06-06 | Hibercell Inc | Derivados de cromenopiridina como inhibidores de la fosfatidilinositol fosfato cinasa |
| CN111615514B (zh) | 2018-01-18 | 2022-10-11 | 奥瑞生物药品公司 | 作为ret激酶抑制剂的取代的吡唑并[4,3-c]吡啶化合物 |
| EP3740491A1 (en) | 2018-01-18 | 2020-11-25 | Array Biopharma, Inc. | Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors |
| WO2019143991A1 (en) | 2018-01-18 | 2019-07-25 | Array Biopharma Inc. | SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS AS RET KINASE INHIBITORS |
| CN110066236B (zh) * | 2018-01-24 | 2023-03-24 | 上海迪诺医药科技有限公司 | 1h-吡咯衍生物、其制备方法、药物组合物及应用 |
| UA127059C2 (uk) * | 2018-03-30 | 2023-03-29 | Ле Лаборатуар Сервьє | Гетеробіциклічні інгібітори mat2a і способи використання для лікування злоякісної пухлини |
| KR20190131981A (ko) * | 2018-05-18 | 2019-11-27 | 재단법인 대구경북첨단의료산업진흥재단 | 외상성 뇌손상 또는 뇌졸중의 예방 또는 치료용 약학적 조성물 |
| MY204443A (en) * | 2018-06-27 | 2024-08-28 | Oscotec Inc | Pyridopyrimidinone derivatives for use as axl inhibitors |
| KR20200022712A (ko) * | 2018-08-23 | 2020-03-04 | 주식회사 오스코텍 | 8-브로모-2-(1-메틸피페리딘-4-일아미노)-4-(4-페녹시페닐아미노)피리도[4,3-d]피리미딘-5(6H)-온 염산염의 결정다형체 및 그 제조방법 |
| EP3849986B1 (en) | 2018-09-10 | 2022-06-08 | Array Biopharma, Inc. | Fused heterocyclic compounds as ret kinase inhibitors |
| CN111285882B (zh) * | 2018-12-07 | 2022-12-02 | 四川科伦博泰生物医药股份有限公司 | 稠环化合物、包含其的药物组合物及其制备方法和用途 |
| CN113874354B (zh) * | 2019-06-04 | 2024-02-20 | 江苏恒瑞医药股份有限公司 | 吡啶酮类衍生物、其制备方法及其在医药上的应用 |
| TW202112784A (zh) | 2019-06-17 | 2021-04-01 | 美商佩特拉製藥公司 | 作為磷脂酸肌醇磷酸激酶抑制劑之𠳭唏并嘧啶衍生物 |
| CN110327347B (zh) * | 2019-08-16 | 2021-06-01 | 陕西科技大学 | G-749在制备抗真菌药物中的应用 |
| WO2021201574A1 (ko) * | 2020-03-31 | 2021-10-07 | 보령제약 주식회사 | Pi3k 저해제로서의 화합물의 제조방법 및 이의 제조를 위한 중간체 화합물 |
| CN113493453B (zh) * | 2020-04-07 | 2023-06-16 | 江苏恒瑞医药股份有限公司 | 稠合芳香环类衍生物、其制备方法及其在医药上的应用 |
| TW202208355A (zh) | 2020-05-04 | 2022-03-01 | 美商安進公司 | 作為骨髓細胞觸發受體2促效劑之雜環化合物及使用方法 |
| PE20230609A1 (es) | 2020-05-04 | 2023-04-13 | Amgen Inc | Compuestos heterociclicos como agonistas del receptor de activacion expresado en las celulas mieloides 2 y metodos de uso |
| WO2021257857A1 (en) * | 2020-06-19 | 2021-12-23 | Incyte Corporation | Naphthyridinone compounds as jak2 v617f inhibitors |
| WO2021257863A1 (en) | 2020-06-19 | 2021-12-23 | Incyte Corporation | Pyrrolotriazine compounds as jak2 v617f inhibitors |
| WO2022005175A1 (ko) * | 2020-06-30 | 2022-01-06 | 보령제약 주식회사 | Pi3k 저해제로서의 화합물의 제조방법 및 이의 제조를 위한 중간체 화합물 |
| SMT202500271T1 (it) | 2020-07-02 | 2025-09-12 | Incyte Corp | Composti di urea triciclici come inibitori di v617f di jak2 |
| US11767323B2 (en) | 2020-07-02 | 2023-09-26 | Incyte Corporation | Tricyclic pyridone compounds as JAK2 V617F inhibitors |
| US11661422B2 (en) | 2020-08-27 | 2023-05-30 | Incyte Corporation | Tricyclic urea compounds as JAK2 V617F inhibitors |
| WO2022140231A1 (en) | 2020-12-21 | 2022-06-30 | Incyte Corporation | Deazaguaine compounds as jak2 v617f inhibitors |
| AR125273A1 (es) | 2021-02-25 | 2023-07-05 | Incyte Corp | Lactamas espirocíclicas como inhibidores de jak2 v617f |
| EP4304727A1 (en) * | 2021-03-10 | 2024-01-17 | Blueprint Medicines Corporation | Egfr inhibitors |
| KR20230056824A (ko) * | 2021-10-20 | 2023-04-28 | 전북대학교산학협력단 | Pak4 저해제 및 그의 용도 |
| WO2023076404A1 (en) | 2021-10-27 | 2023-05-04 | Aria Pharmaceuticals, Inc. | Methods for treating systemic lupus erythematosus |
| CR20240191A (es) | 2021-11-12 | 2024-09-13 | Insilico Medicine Ip Ltd | Inhibidores de molécula pequeña de proteasa 1 específica de ubiquitina (usp1) y usos de los mismos |
| CN119173514A (zh) | 2022-03-17 | 2024-12-20 | 因赛特公司 | 作为jak2 v617f抑制剂的三环脲化合物 |
| CN119604504A (zh) * | 2022-09-16 | 2025-03-11 | 四川科伦博泰生物医药股份有限公司 | 一类双并环化合物、其制备方法及用途 |
| WO2024236528A1 (en) * | 2023-05-18 | 2024-11-21 | Insilico Medicine Ip Limited | Small molecule inhibitors of ubiquitin specific protease 1 (usp1) and uses thereof |
| CN121772941A (zh) * | 2023-06-07 | 2026-03-31 | 维申医药(南通)有限公司 | 一种抗体药物偶联物，及其药物组合物、制备和用途 |
| WO2024250985A1 (zh) * | 2023-06-07 | 2024-12-12 | 上海维申医药有限公司 | Toll样受体激动剂杂环类衍生物及其制备和应用 |
| WO2026005530A1 (ko) * | 2024-06-27 | 2026-01-02 | 전북대학교산학협력단 | 신규한 화합물 및 이의 약학적 용도 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP970371A2 (en) | 1996-07-13 | 1998-08-31 | Kathryn Jane Smith | Heterocyclic compounds |
| WO1998037070A1 (en) | 1997-02-21 | 1998-08-27 | Takeda Chemical Industries, Ltd. | Fused ring compounds, process for producing the same and use thereof |
| WO2006119542A1 (en) * | 2005-05-12 | 2006-11-16 | Cytopia Research Pty Ltd | A crystal structure and uses thereof |
| US7593820B2 (en) | 2005-05-12 | 2009-09-22 | Cytopia Research Pty Ltd | Crystal structure of human Janus Kinase 2 (JAK2) and uses thereof |
| JO2783B1 (en) * | 2005-09-30 | 2014-03-15 | نوفارتيس ايه جي | Compounds 2-Amino-7, 8-dihydro-6H-Bayredo (3,4-D) Pyrimidine-5-Ones |
| TW200942537A (en) | 2008-02-01 | 2009-10-16 | Irm Llc | Compounds and compositions as kinase inhibitors |
| US8383635B2 (en) | 2008-08-12 | 2013-02-26 | Glaxosmithkline Llc | Chemical compounds |
-
2010
- 2010-10-29 SG SG10201407012XA patent/SG10201407012XA/en unknown
- 2010-10-29 KR KR1020127011750A patent/KR101690358B1/ko active Active
- 2010-10-29 EA EA201290237A patent/EA029273B1/ru not_active IP Right Cessation
- 2010-10-29 MX MX2012004846A patent/MX2012004846A/es active IP Right Grant
- 2010-10-29 WO PCT/US2010/054853 patent/WO2011053861A1/en not_active Ceased
- 2010-10-29 BR BR112012010085A patent/BR112012010085B1/pt active IP Right Grant
- 2010-10-29 US US12/916,368 patent/US8404677B2/en active Active
- 2010-10-29 ES ES10827573.6T patent/ES2658290T3/es active Active
- 2010-10-29 NZ NZ630860A patent/NZ630860A/en unknown
- 2010-10-29 NZ NZ599040A patent/NZ599040A/en unknown
- 2010-10-29 TR TR2018/02464T patent/TR201802464T4/tr unknown
- 2010-10-29 CA CA2779105A patent/CA2779105C/en active Active
- 2010-10-29 JP JP2012537147A patent/JP5993742B2/ja active Active
- 2010-10-29 CN CN201080049613.4A patent/CN102695416B/zh active Active
- 2010-10-29 MY MYPI2012001886A patent/MY173494A/en unknown
- 2010-10-29 EP EP10827573.6A patent/EP2493313B1/en active Active
-
2012
- 2012-04-26 CL CL2012001073A patent/CL2012001073A1/es unknown
- 2012-04-29 IL IL219447A patent/IL219447A/en active IP Right Grant
- 2012-05-25 ZA ZA2012/03842A patent/ZA201203842B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013509438A5 (https=) | ||
| JP5834347B2 (ja) | チロシンキナーゼ活性阻害作用を有する新規な縮合ピリミジン誘導体 | |
| JP7318889B2 (ja) | 化合物 | |
| CN109641899B (zh) | 作为内体Toll样受体抑制剂的化合物及组合物 | |
| US10258626B2 (en) | Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them | |
| JP6736559B2 (ja) | トリアゾロピリミジン化合物およびその使用 | |
| CA2779105C (en) | Kinase inhibitors | |
| KR102405462B1 (ko) | Wee-1 카이네이즈 억제제로 유용한 피리미도피리미디논 | |
| ES2715325T3 (es) | Derivados de 6-bencilo-6H-pirido[3.2-e][1.2.4]triazolo[1,5-c]pirimidina-5-ona y 6-bencilo-[1.2.4]triazolo[1,5-c]pteridina-5(6H)-ona como inhibidores de PDE1 para el tratamiento, p. ej. trastornos neurológicos | |
| ES2724525T3 (es) | Inhibidores selectivos de FAK | |
| CN104860891B (zh) | 芳氨基嘧啶类化合物及其应用以及由其制备的药物组合物和药用组合物 | |
| EP3846800A1 (en) | Compounds for the degradation of brd9 or mth1 | |
| RU2019115115A (ru) | Производные пиперидина в качестве ингибиторов убиквитин-специфической протеазы 7 | |
| AU2018200271A1 (en) | Compounds | |
| ES2635003T3 (es) | Dihidroquinoxalinonas y dihidropiridopirazinonas modificadas inhibidoras de proteína BET | |
| JP2019535664A5 (https=) | ||
| AR087336A1 (es) | Compuestos de 2-(2,4,5-anilino sustituido)pirimidina | |
| JP2009519979A5 (https=) | ||
| NZ629442A (en) | Heterocyclyl compounds as mek inhibitors | |
| TW201219398A (en) | Furo[3,2-d]pyrimidine compounds | |
| CA2491500A1 (en) | Substituted imidazotriazines | |
| WO2022170164A1 (en) | Sulfonamides with egfr inhibition activities and their use thereof | |
| JP2018529724A (ja) | キナーゼ阻害剤としての縮合ピリジン誘導体 | |
| JP7667856B2 (ja) | エンドソームトル様受容体を制御する新規小分子化合物及びこれを用いた自己免疫疾患治療剤 | |
| HK40111144A (zh) | Brm靶向化合物和相关的使用方法 |